Experimental acute pancreatitis induced by excessive doses of caerulein in rats; protective and therapeutic effects of trypsin inhibitor urinastatin and CCK receptor antagonist CR1392.
Tani
S
S
D000208:Acute Disease; D000818:Animals; D002108:Ceruletide / Q000008:administration & dosage; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005973:Glutamine / Q000031:analogs & derivatives*; D006023:Glycoproteins / Q000627:therapeutic use*; D007700:Kinetics; D008297:Male; D008854:Microscopy, Electron; D010195:Pancreatitis / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D011377:Proglumide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D011949:Receptors, Cholecystokinin / Q000187:drug effects; D014361:Trypsin Inhibitors
D006023:Glycoproteins; D011949:Receptors, Cholecystokinin; D014361:Trypsin Inhibitors; D005973:Glutamine; D002108:Ceruletide; C048183:CR 1392; D011377:Proglumide; C028665:urinastatin